Tecentriq
Roche’s Tecentriq/Avastin combo gets liver cancer nod
George Underwood
Avastin, Liver cancer, Roche, Tecentriq
0 Comment
Market Access/ News/ News/ News/ Oncology/ Top stories
NICE recommends Roche’s Tecentriq in ES-SCLC following price rethink
Richard Staines
cancer, ES-SCLC, market access, NICE, Roche, small cell lung cancer, Tecentriq
0 Comment
News/ News/ Oncology/ Top stories
Roche’s Tecentriq gains new first-line lung cancer use
Richard Staines
Bristol-Myers Squibb, cancer, lung cancer, Merck & Co, Roche, Tecentriq
0 Comment
Roche’s TIGIT drug shows promise in untreated lung cancer
Richard Staines
cancer, immunotherapy, lung cancer, Roche, Tecentriq
0 Comment
Merck & Co squares up to Roche with Keytruda data in triple-negative breast cancer
Phil Taylor
immuno-oncology, Keytruda, Merck & Co, Oncology, Roche, Tecentriq, triple negative breast cancer
0 Comment
News/ News/ Oncology/ Top stories
FDA to quickly review Roche’s chemo-free lung cancer regimen
Richard Staines
cancer, immunotherapy, Keytruda, lung cancer, Roche, Tecentriq
0 Comment
Market Access/ News/ News/ News/ Oncology
Roche files Tecentriq, Avastin combo as a liver cancer therapy
Phil Taylor
bladder cancer, immuno-oncology, Liver cancer, Oncology, Roche, Tecentriq
0 Comment
Roche steps up Merck challenge with first-line NSCLC approval in US
Phil Taylor
first-line lung cancer, immuno-oncology, Keytruda, Merck & Co, Non-small cell lung cancer, Roche, Tecentriq
0 Comment